Randomized trial of platinum based combination chemotherapy with or without Zoledronic acid as first line therapy for non-small cell lung cancer with bone metastases stratified by bone marker (TORG0706). - Randomized trial of platinum based combination chemotherapy with or without Zoledronic acid as first line therapy for non-small cell lung cancer with bone metastases stratified by bone marker (TORG0706).

Thoracic Oncology Research Group (TORG)0 个研究点目标入组 160 人开始时间: 2009年5月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Sever allergy 2. Required radiation or operation for bone metastases 3. Hypercalcemia 4. History of using bisphosphonate 5. Massive pleural effusion, ascites and pericardial effusion required drainage 6. Symptomatic brain metastasis 7. Patients with serious infections or suspected infections 8. Patients who need dental treatment 9. Active ineterstitial pneumonitis 10. Active concomitant malignancy 11. Pregnant or lactating women 12. Acute Myocardial Infarction within 6 months. 13. Patinets with uncontroled complications 14. Psychological symptoms not suitable for this study 15. other conditions not suitable for this study

发起方

Thoracic Oncology Research Group (TORG)